Glafabra Therapeutics
Glafabra is a biotherapeutics development company focused on bringing its Live-cel technology for cell-based gene therapy into the clinic.
- Headquarters
- United StatesSource: RevenueBaseRetrieved October 13, 2026
- Employee range
- 1 to 10Source: RevenueBaseRetrieved October 13, 2026
- Published list appearances
- 1 supported appearance ↗Source: RevenueBase lists
What does Glafabra Therapeutics do?
The company states that its approach for Fabry disease improves effectiveness compared with enzyme replacement therapy. The company is bringing a long-acting therapy into the clinic.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Company lists.
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Share your recognition
Embeddable award for your website
#24 Familial hypercholesterolemia treatment companies
Snapshot: September 19, 2026
Sources & data notes.
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 19, 2026. How the company lists are built.
Something changed?
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
One company is just the start.
Explore more companies by name, headquarters and business focus.